2-(2-Pyridon-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate | CAS:125700-71-2

We serve 2-(2-Pyridon-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate CAS:125700-71-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-(2-Pyridon-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate

Chemical Name:2-(2-Pyridon-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate
CAS.NO:125700-71-2
Synonyms:O-(1,2-Dihydro-2-oxo-1-pyridyl)-N,N,N‘,N‘-tetramethyluronium tetrafluoroborate;O-[2-Oxo-1(2H)-pyridyl]-N,N,N',N'-tetramethyluronium Tetrafluoroborate;TPTU
Molecular Formula:C10H16BF4N3O2
Molecular Weight:297.05800
 
Physical and Chemical Properties:
Melting point:140oC;
 
Specification:
Appearance:White powder
Purity(HPLC):≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:As a condensation reagent
 



Contact us for information like 2-(2-Pyridon-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,TPTU physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,O-[2-Oxo-1(2H)-pyridyl]-N,N,N’,N’-tetramethyluronium Tetrafluoroborate Use and application,TPTU technical grade,usp/ep/jp grade.


Related News: A key publication in a preclinical model demonstrated rigosertib’s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: “A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.” Cell 165, 643).ribothymidine manufacturer People should also avoid having visitors, although it is okay for family and friends to drop off parcels or medicines, for example.5-iodo-1-pentanol supplier Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.ethyl 4-methoxy-3-oxobutanoate vendor Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.Both patients were being treated in isolation units at a Manila hospital.